Becton Dickinson Posts 7 Percent Q2 Growth

Lower-than-expected growth in its diagnostics business was offset by larger gains in its BD Medical and BD Biosciences businesses.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories